Press Releases

The latest announcements from Protagen, from our research programs to commercialization and partnerships—scroll down to find out more about what’s been happening in Dortmund and beyond.

For more information on any of the news items featured on this page, please contact:

Contact
Dr Georg Lautscham
CEO
bd@protagen.com
T +49 231 9742 6300

Media Enquiries
Dr Clare Russell
Managing Director, BioStrata, UK
crussell@biostratamarketing.com
T +44 1223 253787

Protagen AG Announces Changes to Their Management Board

Protagen AG. a leading provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology and autoimmune disease, today announced changes to their Management Board. Dr. Georg Lautscham will join the...

read more

Leadership

Protagen’s corporate leadership team combines over 40 years of commercial expertise and experience within the biotechnology industry, with a background spanning immunology, oncology, biomarker discovery and more.

Scientific Advisory Board

Protagen is currently setting up an international scientific advisory board with key opinion leaders from the immuno-oncology and autoimmune disease fields. These expert panels will support our efforts in engaging with the medical and scientific community to develop products that are aimed at market needs.

Investors

Protagen has a number of established and committed investors, but is always looking at entering into new partnerships to help progress its research and commercialization efforts. If you are interested in investing in the company, please contact us.

Careers

Protagen is always looking to expand its talented and experienced team. For information on some of the job roles available, simply click below.

Our Company

Protagen is dedicated to the development of powerful diagnostic tools that aid successful therapeutic development and facilitate improved treatment strategies in the areas of autoimmune disease and immuno-oncology.

Stratified News

Here you will find our quarterly newsletter, “Stratified News from Dortmund”. With our newsletter we intend to regularly update you on developments at Protagen in a fresh and colorful format and we hope that you like it.

Get in touch

Improving the treatment of cancer and autoimmune disease is our passion, and we always welcome the chance to discuss these topics with current and prospective customers, patients and clinicians alike.

We sometimes like to share the latest industry insights and company news, would you like to be added to our database?

12 + 10 =

Copyright © 1997-2018
Protagen AGDortmund, Germany